Мультифокальний папілярний рак щитоподібної залози у дітей і дорослих. Лекція
DOI:
https://doi.org/10.30978/CEES-2022-3-47Ключові слова:
папілярний рак щитоподібної залози, предиктори, мультифокальністьАнотація
Рак щитоподібної залози (РЩЗ) посідає 9‑те місце в світі за рівнем захворюваності. У 2020 р. у світі зареєстровано 586 тис. випадків РЩЗ. Рівень захворюваності серед жінок становить 10,1 на 100 тис. населення, серед чоловіків — 3,1 на 100 тис. населення. В Україні у 2019 р. стандартизований показник захворюваності на РЩЗ (світовий стандарт) становив 6,9 на 100 тис. населення (2,8 — серед чоловіків, 10,5 — серед жінок). У структурі захворюваності на злоякісні новоутворення РЩЗ посідає перше місце серед жінок віком 18—29 років (19,9 %), четверте місце — серед чоловіків віком 18—29 років (8,3 %), а також серед жінок віком 30—54 роки (8,1 %). Останніх 40 років у більшості країн спостерігається зростання рівня захворюваності на РЩЗ (зокрема на папілярний рак щитоподібної залози (ПРЩЗ)), що пояснюють різними чинниками, наприклад, надмірною діагностикою, зміною поширеності модифікованих чинників ризику. В Україні за період з 1989 до 2012 р. рівень захворюваності на РЩЗ серед чоловіків зріс на 115 %, серед жінок — на 137 %, щорічний приріст захворюваності на РЩЗ для чоловіків і жінок становив 5 та 6 % відповідно. Мультифокальність при ПРЩЗ є характерною ознакою, що набагато частіше трапляється в дитячому віці, ніж у дорослих, але кількість досліджень у дітей обмежена, що пов’язують з меншою поширеністю захворювання у дітей. Дані досліджень щодо чинників прогнозування мультифокальності та її ролі у впливі на рецидив, персистенцію і виживаність пацієнтів з ПРЩЗ суперечливі як у дорослих, так і у дітей. Серед чинників ризику мультифокальності менша кількість суперечок стосується зв’язків з метастазуванням у лімфатичні вузли, опроміненням в анамнезі, дитячим віком, а для двобічності — з мультифокальністю первинної частки та наявністю контралатеральних доброякісних вузлів (у дорослих). Інші чинники як предиктори мультифокальності мають суперечливе значення та варті уваги у подальших дослідженнях. Визначення надійних предикторів мультифокальності, особливо за допомогою аналізу доопераційних даних, а також стратифікація ризику мультифокальності дадуть змогу полегшити складний процес прийняття рішень для правильної тактики лікування дітей і дорослих з ПРЩЗ.
Посилання
Biuleten Natsionalnoho kantser-reiestru № 22 Rak v Ukraini 2019-2020 [in Ukrainian].
Huda B. B. Vysokodyferentsiiovanyi rak shchytopodibnoi zalozy: molekuliarno-biolohichni ta klinichni aspekty, optymizatsiia khirurhichnoho likuvannia ta pisliaoperatsiinoi reabilitatsii patsiientiv : avtoref. dys.... d-ra med. nauk : 14.01.14. K.; 2019 [in Ukrainian].
Zelinska NB, Larin OS. Patolohiia shchytopodibnoi zalozy u dytiachoho naselennia Ukrainy. Klinichna endokrynolohiia ta endokrynna khirurhiia. 2016;(3):76-81 [in Ukrainian].
Kobrynska N. Ia. Kliniko-morfolohichna kharakterystyka ta khirurhichne likuvannia multyfokalnykh vysokodyferentsiiovanykh tyreoidnykh kartsynom: avtoref. dys.... kand. med. nauk: 14.01.03. K.; 2020:23 [in Ukrainian].
Lishchynskyi PO, Palamarchuk VO, Zemskov SV, Tovkai OA. Kliniko-morfolohichni chynnyky, yaki pidvyshchuiut ryzyk lokorehionarnoho metastazuvannia papiliarnoho raku shchytopodibnoi zalozy Clinical Endocrinology and Endocrine Surgery. 2021;(3). DOI: http://doi.org/10.30978/CEES-2021-3-7 [in Ukrainian].
Nechai O, Kvitka D, Lishchynskyi P, Sichynava R. Mizhnarodnyi zhurnal endokrynolohii. 2021; (3):272-7. https://doi.org/10.22141/2224-0721.16.3.2020.205278 [in Ukrainian].
Nechai OP, Kvitka DM, Lishchynskyi PO ta in. Vplyv ozhyrinnia na rozvytok tyreoidnoho raku: rezultaty vlasnykh doslidzhen. Klin. endokrynolohiia ta endokrynna khirurhiia. 2020;(4):39-49. DOI: http://doi.org/10.30978/CEES-2020-4-39 [in Ukrainian].
Reiti AO. Osoblyvosti diahnostyky ta likuvannia dribnovohnyshchevoi patolohii shchytopodibnoi zalozy: avtoref. dys. ...kand. med. nauk: 14.01.03. K.; 2015:18 [in Ukrainian].
Sydorenko OM, Sydorenko MO, Tymoshev M P. Epidemiolohiia raku shchytovydnoi zalozy naprykintsi KhKh ta na pochatku KhKhI stolittia v Ukraini ta Zaporizkii oblasti. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky. 2018;11(3):322-5 [in Ukrainian].
Statystychno-analitychnyi dovidnyk dytiachoho endokrynoloha za 2017 rik. K.; 2018:102 [in Ukrainian].
Trydtsiat p’iat rokiv Chornobylskoi katastrofy: radiolohichni ta medychni naslidky, stratehii zakhystu ta vidrodzhennia : Natsionalna dopovid Ukrainy. K.; 2021. 283 r. ISBN 978-966-7656-10-2 [in Ukrainian].
Cherenko SM, Smoliar VA, Shapoval NO. Rak shchytopodibnoi zalozy sered «ditei Chornobylia»: chy aktualna tsia problema cherez 30 rokiv pislia avarii na ChAES? Clinical Endocrinology and Endocrine Surgery. 2017;(1):30-9 [in Ukrainian].
Al Nofal A, Gionfriddo MR, Javed A, et al. Accuracy of thyroid nodule sonography for the detection of thyroid cancer in children: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2016 Mar;84(3):423-30. doi: 10.1111/cen.12786. Epub 2015 Apr 21. PMID: 25845503.
Alzahrani AS, Alswailem M, Alswailem AA, et al. Genetic alterations in pediatric thyroid cancer using a Comprehensive Childhood Cancer Gene Panel. J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa389. doi: 10.1210/clinem/dgaa389. PMID: 32556222.
Bahat Dinur A, Quint E, Lupo L, Fraenkel M, El-Saied S, Joshua BZ. Limitations of ultrasound in predicting bilaterality vs unilaterality of well-differentiated carcinoma of the thyroid. Am J Otolaryngol. 2020 Jul-Aug;41(4):102543. doi: 10.1016/j.amjoto.2020.102543. Epub 2020 May 8. PMID: 32474327.
Banik GL, Shindo ML, Kraimer KL, et al. Prevalence and risk factors for multifocality in pediatric thyroid cancer. JAMA Otolaryngol Head Neck Surg. 2021 Dec 1;147(12):1100-6. doi: 10.1001/jamaoto.2021.3077. PMID: 34734994; PMCID: PMC8569596.
Baumgarten H, Jenks CM, Isaza A, et al. Bilateral papillary thyroid cancer in children: Risk factors and frequency of postoperative diagnosis. J Pediatr Surg. 2020 Jun;55(6):1117-22. doi: 10.1016/j.jpedsurg.2020.02.040. Epub 2020 Feb 27. PMID: 32171533.
Bogdanova TI, Saenko VA, Hashimoto Y, et al. Papillary thyroid carcinoma in Ukraine after Chernobyl and in Japan after Fukushima: different histopathological scenarios. Thyroid. 2021 Sep;31(9):1322-34. doi: 10.1089/thy.2020.0308. Epub 2020 Dec 3. PMID: 33143557.
Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014 Apr 10;170(5):R203-11. doi: 10.1530/EJE-13-0995. PMID: 24536085.
Canfarotta M, Moote D, Finck C, et al. McGill Thyroid Nodule Score in differentiating benign and malignant pediatric thyroid nodules: a pilot study. Otolaryngol Head Neck Surg. 2017 Oct;157(4):589-95. doi: 10.1177/0194599817715629. Epub 2017 Jun 27. PMID: 28653562.
Chen X, Zhong Z, Song M, et al. Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: a retrospective study. Gland Surg. 2020 Aug;9(4):872-8. doi: 10.21037/gs-19-157. PMID: 32953595; PMCID: PMC7475348.
Cherella CE, Richman DM, Liu E, et al. Predictors of bilateral disease in pediatric differentiated thyroid cancer. J Clin Endocrinol Metab. 2021;106(10):e4242-e4250. doi:10.1210/clinem/dgab210.
Cherenko SM, Larin OS, Gorobeyko MB, Sichynava RM. Clinical analysis of thyroid cancer in adult patients exposed to ionizing radiation due to the Chernobyl nuclear accident: 5-year comparative investigations based on the results of surgical treatment. World J Surg. 2004 Nov;28(11):1071-4. doi: 10.1007/s00268-004-7561-7. PMID: 15490064.
Choi WR, Roh JL, Gong G, et al. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. Oral Oncol. 2019 Jul;94:106-10. doi: 10.1016/j.oraloncology.2019.05.023. Epub 2019 May 29. PMID: 31178204.
Cordioli MI, Moraes L, Bastos AU, et al. Fusion oncogenes are the main genetic events found in the sporadic papillary thyroid carcinomas from children. Thyroid. 2017;27:182-8.
Cordioli MI, Moraes L, Cury AN, Cerutti JM. Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma? Endocr Relat Cancer. 2015 Dec;22(6):R311-24. doi: 10.1530/ERC-15-0381. Epub 2015 Aug 25. PMID: 26307021.
Creo A, Alahdab F, Al Nofal A, Thomas K, Kolbe A, Pittock S. Diagnostic accuracy of the McGill thyroid nodule score in paediatric patients. Clin Endocrinol (Oxf). 2019 Jan;90(1):200-7. doi: 10.1111/cen.13878. Epub 2018 Nov 12. PMID: 30326152.
Cui N, Sun Q, Chen L. A meta-analysis of the influence of body mass index on the clinicopathologic progression of papillary thyroid carcinoma. Medicine (Baltimore). 2021 Aug 13;100(32):e26882. doi: 10.1097/MD.0000000000026882. PMID: 34397906; PMCID: PMC8360437.
Dai Q, Liu D, Tao Y, et al. Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis. Eur Radiol. 2022 Feb 28. doi: 10.1007/s00330-022-08565-1. Epub ahead of print. PMID: 35226156.
Demidchik YE, Demidchik EP, Reiners C, et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg. 2006;243(4):525-32. doi:10.1097/01.sla.0000205977.74806.0b.
Dong S, Xia Q, Wu YJ. High TPOAb levels (> 1300 IU/mL) indicate multifocal PTC in Hashimoto’s thyroiditis patients and support total thyroidectomy. Otolaryngol Head Neck Surg. 2015 Jul;153(1):20-6. doi: 10.1177/0194599815581831. Epub 2015 Apr 27. PMID: 25917667.
Dong S, Xie XJ, Xia Q, Wu YJ. Indicators of multifocality in papillary thyroid carcinoma concurrent with Hashimoto’s thyroiditis. Am J Cancer Res. 2019 Aug 1;9(8):1786-95. PMID: 31497359; PMCID: PMC6726987.
Economides A, Giannakou K, Mamais I, Economides PA, Papageorgis P. Association between aggressive clinicopathologic features of papillary thyroid carcinoma and body mass index: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021 Jun 30;12:692879. doi: 10.3389/fendo.2021.692879. PMID: 34276564; PMCID: PMC8279812.
Feng J, Gan X, Shen F, Cai W, Xu B. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Int J Surg. 2018 Apr;52:166-70. doi: 10.1016/j.ijsu.2018.02.029. Epub 2018 Feb 23. PMID: 29481991.
Feng JW, Qu Z, Qin AC, Pan H, Ye J, Jiang Y. Significance of multifocality in papillary thyroid carcinoma. Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-8. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19. PMID: 32732090.
Feng JW, Ye J, Wu WX, et al. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma. Front Endocrinol (Lausanne). 2020 Oct 8;11:553577. doi: 10.3389/fendo.2020.553577. PMID: 33133013; PMCID: PMC7578423.
Fornwalt B, Melachuri M, Kubina M, McDaniel J, Jeyakumar A. Pediatric thyroid nodules: ultrasound characteristics as indicators of malignancy. OTO Open. 2022 Mar 8;6(1):2473974X211073702. doi: 10.1177/2473974X211073702. PMID: 35282593; PMCID: PMC8908396.
Franchini F, Palatucci G, Colao A, Ungaro P, Macchia PE, Nettore IC. Obesity and thyroid cancer risk: an update. Int J Environ Res Public Health. 2022 Jan 20;19(3):1116. doi: 10.3390/ijerph19031116. PMID: 35162142; PMCID: PMC8834607.
Francis GL, Waguespack SG, Bauer AJ, et al. American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. PMID: 25900731; PMCID: PMC4854274.
Fridman M, Savva N, Krasko O, et al. Initial presentation and late results of treatment of post-Chernobyl papillary thyroid carcinoma in children and adolescents of Belarus. J Clin Endocrinol Metab. 2014 Aug;99(8):2932-41. doi: 10.1210/jc.2013-3131. Epub 2014 May 13. PMID: 24823453.
Genpeng L, Jianyong L, Jiaying Y, et al. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer. Medicine (Baltimore). 2018 Feb;97(5):e9619. doi: 10.1097/MD.0000000000009619.
Geron Y, Benbassat C, Shteinshneider M, et al. Multifocality is not an independent prognostic factor in papillary thyroid cancer: a propensity score-matching analysis. Thyroid. 2019 Apr;29(4):513-22. doi: 10.1089/thy.2018.0547. Epub 2019 Mar 15. PMID: 30799769.
Guda B, Kovalenko A, Bolgov M, Pushkarev V, Tronko M. Multifocal differentiated thyroid cancer. Оnkоlogia. 2019;21(2):125-9.
Gui Y, Huang D, Hou Y, Wei X, Zhang J, Wang J. Predictive factors for recurrence of papillary thyroid carcinoma in children and adolescents. Front Oncol. 2022 Feb 24;12:833775. doi: 10.3389/fonc.2022.833775. PMID: 35280803; PMCID: PMC8909140.
Harries V, Wang LY, McGill M, et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery. 2020;167(1):10-17. doi:10.1016/j.surg.2019.03.031.
Hidayat K, Du X, Shi BM. Body fatness at a young age and risks of eight types of cancer: systematic review and meta-analysis of observational studies. Obes Rev. 2018 Oct;19(10):1385-94. doi: 10.1111/obr.12705. Epub 2018 Jul 25. PMID: 30047231.
Hîtu L, Stefan PA, Piciu D. Total tumor diameter and unilateral multifocality as independent predictor factors for metastatic papillary thyroid microcarcinoma. J Clin Med. 2021 Aug 20;10(16):3707. doi: 10.3390/jcm10163707. PMID: 34442001; PMCID: PMC8396836.
Hwang E, Pakdaman MN, Tamilia M, et al. Bilateral papillary thyroid cancer and associated histopathologic findings. J Otolaryngol Head Neck Surg. 2010 Jun;39(3):284-7. PMID: 20470673.
Iacobone M, Jansson S, Barczyński M, Goretzki P. Multifocal papillary thyroid carcinoma-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2014 Feb;399(2):141-54. doi: 10.1007/s00423-013-1145-7. Epub 2013 Nov 22. PMID: 24263684.
Iglesias ML, Schmidt A, Ghuzlan AA, et al. Radiation exposure and thyroid cancer: a review. Arch Endocrinol Metab. 2017 Mar-Apr;61(2):180-7. doi: 10.1590/2359-3997000000257. Epub 2017 Feb 16. PMID: 28225863.
Janus D, Wojcik M, Kalicka-Kasperczyk A, et al. Novel insights in ultrasound evaluation of thyroid gland in children with papillary thyroid carcinoma. Neuro Endocrinol Lett. 2017 Oct;38(5):367-74. PMID: 29106792.
Jeon YW, Gwak HG, Lim ST, Schneider J, Suh YJ. Long-term prognosis of unilateral and multifocal papillary thyroid microcarcinoma after unilateral lobectomy versus total thyroidectomy. Ann Surg Oncol. 2019 Sep;26(9):2952-8. doi: 10.1245/s10434-019-07482-w. Epub 2019 Jul 1. PMID: 31264119.
Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: A meta-analysis. Int J Surg. 2018 Feb;50:121-5. doi: 10.1016/j.ijsu.2017.12.035. Epub 2018 Jan 11. PMID: 29337178.
Kaliszewski K, Diakowska D, Rzeszutko M, Rudnicki J. Obesity and overweight are associated with minimal extrathyroidal extension, multifocality and bilaterality of papillary thyroid cancer. J Clin Med. 2021 Mar 2;10(5):970. doi: 10.3390/jcm10050970. PMID: 33801171; PMCID: PMC7957777.
Kim H, Kwon H, Moon BI. Association of multifocality with prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021 Oct 1;147(10):847-54. doi: 10.1001/jamaoto.2021.1976. PMID: 34410321; PMCID: PMC8377609.
Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg. 2013 Feb;37(2):376-84. doi: 10.1007/s00268-012-1835-2. PMID: 23135422.
Kim JM. The clinical importance of multifocality on tumor recurrence in papillary thyroid carcinoma. Gland Surg. 2021;10(1):273-8. doi:10.21037/gs-20-603.
Kim K, Lee CR, Kang SW, et al. Clinical assessment of pediatric patients with differentiated thyroid carcinoma: a 30-year experience at a single institution. World J Surg. 2020;44:338-92. https://doi.org/10.1007/s00268-020-05598-9.
Kitahara CM, Sosa JA. Understanding the ever-changing incidence of thyroid cancer. Nat Rev Endocrinol. 2020 Nov;16(11):617-8. doi: 10.1038/s41574-020-00414-9. PMID: 32895503; PMCID: PMC7476643.
Kuhn E, Teller L, Piana S, Rosai J, Merino MJ. Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature. Endocr Pathol. 2012;23(2):101-7. doi:10.1007/s12022-012-9202-2.
Lee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol. 2013 Feb 15;168(3):343-9. doi: 10.1530/EJE-12-0903. PMID: 23211578.
Lee YA, Jung HW, Kim HY, et al. Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years. J Clin Endocrinol Metab. 2015 Apr;100(4):1619-29. doi: 10.1210/jc.2014-3647. Epub 2015 Jan 29. PMID: 25632969.
Lee YC, Eun YG, Sohn YM, et al. Predictive factors for occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma by preoperative ultrasonographic and pathological features. World J Surg. 2015 Jul;39(7):1736-41. doi: 10.1007/s00268-015-3024-6. PMID: 25743485.
Li C, Zhou L, Dionigi G, Li F, Zhao Y, Sun H. The association between tumor tissue calcification, obesity, and thyroid cancer invasiveness in a cohort study. Endocr Pract. 2020 Aug;26(8):830-9. doi: 10.4158/EP-2020-0057. PMID: 33471674.
Li LQ, Hey SY, Andreeva D, et al. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer. Eur J Surg Oncol. 2022 Jan;48(1):14-20. doi: 10.1016/j.ejso.2021.06.033. Epub 2021 Jun 29.
Liang J, Zeng W, Fang F, et al. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients. Acta Otorhinolaryngol Ital. 2017 Oct;37(5):393-400. doi: 10.14639/0392-100X-1709. PMID: 29165434; PMCID: PMC5720867.
Liang W, Sheng L, Zhou L, et al. Risk factors and prediction model for lateral lymph node metastasis of papillary thyroid carcinoma in children and adolescents. Cancer Manag Res. 2021 Feb 16;13:1551-8. doi: 10.2147/CMAR.S295420. PMID: 33623434; PMCID: PMC7896733.
Liu C, Wang S, Zeng W, Guo Y, Liu Z, Huang T. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis. Sci Rep. 2017 May 12;7(1):1846. doi: 10.1038/s41598-017-02165-6. PMID: 28500312; PMCID: PMC5431972.
Liu Z, Hu D, Huang Y, et al. Factors associated with distant metastasis in pediatric thyroid cancer: evaluation of the SEER database. Endocr Connect. 2019 Feb 1;8(2):78-85. doi: 10.1530/EC-18-0441. PMID: 30620713.
Lubin JH, Adams MJ, Shore R, et al. Thyroid cancer following childhood low-dose radiation exposure: a pooled analysis of nine cohorts. J Clin Endocrinol Metab. 2017 Jul 1;102(7):2575-83. doi: 10.1210/jc.2016-3529. PMID: 28323979; PMCID: PMC5505197.
Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit. 2015 Jan 22;21:283-91. doi: 10.12659/MSM.892035. PMID: 25612155; PMCID: PMC4315628.
Ma YJ, Deng XL, Li HQ. BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2015 Aug;35(4):591-99. doi: 10.1007/s11596-015-1476-4. Epub 2015 Jul 31. PMID: 26223933.
Manso J, Censi S, Roberti A, et al. Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden. Ther Adv Endocrinol Metab. 2020 Oct 12;11:2042018820964326. doi: 10.1177/2042018820964326. PMID: 33110488; PMCID: PMC7557686.
Mao J, Zhang Q, Zhang H, Zheng K, Wang R, Wang G. Risk factors for lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020 May 15;11:265. doi: 10.3389/fendo.2020.00265. PMID: 32477264; PMCID: PMC7242632.
Martinez-Rios C, Daneman A, Bajno L, van der Kaay DCM, Moineddin R, Wasserman JD. Utility of adult-based ultrasound malignancy risk stratifications in pediatric thyroid nodules. Pediatr Radiol. 2018 Jan;48(1):74-84. doi: 10.1007/s00247-017-3974-y. Epub 2017 Oct 5. PMID: 28983667.
Memeh K, Ruhle B, Alsafran S, et al. Total thyroidectomy vs thyroid lobectomy for localized papillary thyroid cancer in children: a propensity-matched survival analysis. J Am Coll Surg. 2021 Jul;233(1):39-49. doi: 10.1016/j.jamcollsurg.2021.03.025. Epub 2021 Apr 19. PMID: 33887483.
Mihailovic J, Nikoletic K, Srbovan D. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes. J Nucl Med. 2014 May;55(5):710-7. doi: 10.2967/jnumed.113.130450. Epub 2014 Apr 10. PMID: 24722527.
Mijović T, How J, Pakdaman M, et al. Body mass index in the evaluation of thyroid cancer risk. Thyroid. 2009 May;19(5):467-72. doi: 10.1089/thy.2008.0386. PMID: 19415996.
Min Y, Xiang K, Feng Y, Chen H, Chen J, Wei X, Yin G. Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma. Oral Oncol. 2021 Oct;121:105507. doi: 10.1016/j.oraloncology.2021.105507. Epub 2021 Aug 24. PMID: 34450454.
Moon S, Chung HS, Yu JM, Yoo HJ, Park JH, Kim DS, Park YJ. Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: a meta-analysis of observational studies. Endocrinol Metab (Seoul). 2018 Dec;33(4):473-84. doi: 10.3803/EnM.2018.33.4.473. PMID: 30513562; PMCID: PMC6279904.
Ng SC, Kuo SF, Chen ST, Hsueh C, Huang BY, Lin JD. Therapeutic outcomes of patients with multifocal papillary thyroid microcarcinomas and larger tumors. Int J Endocrinol. 2017;2017:4208178. doi: 10.1155/2017/4208178. Epub 2017 May 31. PMID: 28642790; PMCID: PMC5470030.
Ngo DQ, Le DT, Ngo QX, Van Le Q. Risk factors for lateral lymph node metastasis of papillary thyroid carcinoma in children. J Pediatr Surg. 2022 Jan 22:S0022-3468(22)00080-X. doi: 10.1016/j.jpedsurg.2022.01.017. Epub ahead of print. PMID: 35168812.
Ngo DQ, Ngo QX, Van Le Q. Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma. Int J Pediatr Otorhinolaryngol. 2020 Jun;133:110000. doi: 10.1016/j.ijporl.2020.110000. Epub 2020 Mar 12. PMID: 32200312.
O’Neill RJ, Abd Elwahab S, Kerin MJ, Lowery AJ. Association of BMI with clinicopathological features of papillary thyroid cancer: a systematic review and meta-analysis. World J Surg. 2021 Sep;45(9):2805-15. doi: 10.1007/s00268-021-06193-2. Epub 2021 Jun 16. PMID: 34136926.
Ohira T, Ohtsuru A, Midorikawa S, et al.; Fukushima Health Management Survey group. External Radiation Dose, Obesity, and Risk of Childhood Thyroid Cancer After the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey. Epidemiology. 2019 Nov;30(6):853-60. doi: 10.1097/EDE.0000000000001058. PMID: 31259849.
Onder S, Ozturk Sari S, Yegen G, et al. Classic architecture with multicentricity and local recurrence, and absence of TERT promoter mutations are correlates of BRAF (V600E) harboring pediatric papillary thyroid carcinomas. Endocr Pathol. 2016 Jun;27(2):153-61. doi: 10.1007/s12022-016-9420-0. PMID: 26951110.
Ortega CA, Gallant J, Chen S, et al. Evaluation of thyroid nodule malignant neoplasms and obesity among children and young adults. JAMA Netw Open. 2021;4(7):e2116369. doi:10.1001/jamanetworkopen.2021.16369.
Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, Ringel MD. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab. 2010 Sep;95(9):4244-50. doi: 10.1210/jc.2010-0440. Epub 2010 Jun 2. PMID: 20519347; PMCID: PMC2936072.
Paik C, Osterbauer B, Sahyouni G, et al. Thyroid tumor ratio: Improving the assessment of the impact of size in pediatric thyroid cancer. Head Neck. 2022 Jun;44(6):1342-8. doi: 10.1002/hed.27029. Epub 2022 Mar 23. PMID: 35322489.
Park JS, Son KR, Na DG, Kim E, Kim S. Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system. AJR Am J Roentgenol. 2009 Jan;192(1):66-72. doi: 10.2214/AJR.07.3731. Erratum in: AJR Am J Roentgenol. 2009 Mar;192(3):560. PMID: 19098181.
Park M, Park SH, Kim EK, et al. Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule? BMC Cancer. 2013 Nov 16;13:550. doi: 10.1186/1471-2407-13-550. PMID: 24237991; PMCID: PMC3832886.
Park S, Jeong JS, Ryu HR, et al. Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system. J Korean Med Sci. 2013 May;28(5):693-9. doi: 10.3346/jkms.2013.28.5.693. Epub 2013 May 2. PMID: 23678260; PMCID: PMC3653081.
Park SY, Jung YS, Ryu CH, et al. Identification of occult tumors by whole-specimen mapping in solitary papillary thyroid carcinoma. Endocr Relat Cancer. 2015 Aug;22(4):679-86. doi: 10.1530/ERC-15-0152. Epub 2015 Jun 25. PMID: 26113610.
Paulson VA, Rudzinski ER, Hawkins DS. Thyroid cancer in the pediatric population. Genes (Basel). 2019 Sep 18;10(9):723. doi: 10.3390/genes10090723. PMID: 31540418; PMCID: PMC6771006.
Peccin S, de Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? J Endocrinol Invest. 2002 Jan;25(1):39-43. doi: 10.1007/BF03343959. PMID: 11885575.
Pekova B, Sykorova V, Dvorakova S, et al. RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. Thyroid. 2020 Dec;30(12):1771-80. doi: 10.1089/thy.2019.0802. Epub 2020 Jul 1.
Pekova B, Sykorova V, Mastnikova K, et al. NTRK fusion genes in thyroid carcinomas: clinicopathological characteristics and their impacts on prognosis. Cancers (Basel). 2021 Apr 16;13(8):1932. doi: 10.3390/cancers13081932. PMID: 33923728; PMCID: PMC8073383.
Polat SB, Cakir B, Evranos B, et al. Preoperative predictors and prognosis of bilateral multifocal papillary thyroid carcinomas. Surg Oncol. 2019 Mar;28:145-9. doi: 10.1016/j.suronc.2018.12.004. Epub 2018 Dec 31. PMID: 30851890.
Pyo JS, Sohn JH, Kang G, Kim DH, Yun J. Total surface area is useful for differentiating between aggressive and favorable multifocal papillary thyroid carcinomas. Yonsei Med J. 2015 Mar;56(2):355-61. doi: 10.3349/ymj.2015.56.2.355. PMID: 25683981; PMCID: PMC4329344.
Pyo JS, Sohn JH, Kang G. Detection of tumor multifocality is important for prediction of tumor recurrence in papillary thyroid microcarcinoma: a retrospective study and meta-analysis. J Pathol Transl Med. 2016 Jul;50(4):278-86. doi: 10.4132/jptm.2016.03.29. Epub 2016 Jun 6. PMID: 27271109; PMCID: PMC4963970.
Qi ZJ, Liu LF, Cheng L, et al. [Risk factors analyses for lateral neck lymph node metastasis in papillary thyroid carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Jul;33(7):603-6. Chinese. doi: 10.13201/j.issn.1001-1781.2019.07.007. PMID: 31327195.
Qu N, Zhang L, Lu ZW, et al. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature. Tumour Biol. 2016 Jun;37(6):7797-808. doi: 10.1007/s13277-015-4532-6. Epub 2015 Dec 22. PMID: 26695148.
Qu N, Zhang L, Wu WL, et al. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer. Tumour Biol. 2016 Jul;37(7):8783-9. doi: 10.1007/s13277-015-4533-5. Epub 2016 Jan 7. PMID: 26743781.
Ren PY, Liu J, Xue S, Chen G. Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto’s thyroiditis. Asian J Surg. 2019 Jan;42(1):112-9. doi: 10.1016/j.asjsur.2017.10.006. Epub 2017 Dec 15. PMID: 29254871.
Richman DM, Benson CB, Doubilet PM, et al. Assessment of American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) for Pediatric Thyroid Nodules. Radiology. 2020 Feb;294(2):415-20. doi: 10.1148/radiol.2019191326. Epub 2019 Dec 10. PMID: 31821121.
Rotondi M, Castagna MG, Cappelli C, et al. Does not modify the risk of differentiated thyroid cancer in a cytological series of thyroid nodules. Eur Thyroid J. 2016 Jul;5(2):125-31. doi: 10.1159/000445054. Epub 2016 Apr 27. PMID: 27493887; PMCID: PMC4949374.
Rubinstein JC, Herrick-Reynolds K, Dinauer C, et al. Recurrence and complications in pediatric and adolescent papillary thyroid cancer in a high-volume practice. J Surg Res. 2020 May;249:58-66. doi: 10.1016/j.jss.2019.12.002. Epub 2020 Jan 7. PMID: 31923715.
Scappaticcio L, Maiorino MI, Iorio S, et al. Exploring the performance of ultrasound risk stratification systems in thyroid nodules of pediatric patients. Cancers (Basel). 2021 Oct 22;13(21):5304. doi: 10.3390/cancers13215304. PMID: 34771467; PMCID: PMC8582568.
Schmid D, Ricci C, Behrens G, Leitzmann MF. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev. 2015 Dec;16(12):1042-54. doi: 10.1111/obr.12321. Epub 2015 Sep 14. PMID: 26365757.
So YK, Kim MW, Son YI. Multifocality and bilaterality of papillary thyroid microcarcinoma. Clin Exp Otorhinolaryngol. 2015;8(2):174-8. doi:10.3342/ceo.2015.8.2.174.
Spinelli C, Tognetti F, Strambi S, Morganti R, Massimino M, Collini P. Cervical lymph node metastases of papillary thyroid carcinoma, in the central and lateral compartments, in children and adolescents: predictive factors. World J Surg. 2018 Aug;42(8):2444-53. doi: 10.1007/s00268-018-4487-z. PMID: 29383423.
Sudoko CK, Jenks CM, Bauer AJ, et al. Thyroid lobectomy for t1 papillary thyroid carcinoma in pediatric patients. JAMA Otolaryngol Head Neck Surg. 2021 Nov 1;147(11):943-50. doi: 10.1001/jamaoto.2021.2359. PMID: 34554217; PMCID: PMC8461547.
Sugino K, Nagahama M, Kitagawa W, et al. Risk stratification of pediatric patients with differentiated thyroid cancer: is total thyroidectomy necessary for patients at any risk? Thyroid. 2020 Apr;30(4):548-56. doi: 10.1089/thy.2019.0231. Epub 2020 Mar 11. PMID: 31910105.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-49. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
Sur ML, Gaga R, Lazăr C, Lazea C, Aldea C, Sur D. Papillary thyroid carcinoma in children with Hashimoto’s thyroiditis — a review of the literature between 2000 and 2020. J Pediatr Endocrinol Metab. 2020 Nov 12;33(12):1511-7. doi: 10.1515/jpem-2020-0383. PMID: 33180046.
Tam AA, Özdemir D, Çuhacı N, et al. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer. Endocrine. 2016 Sep;53(3):774-83. doi: 10.1007/s12020-016-0955-0. Epub 2016 Apr 18. PMID: 27090526.
Tam AA, Özdemir D, Çuhacı N, et al. Can ratio of the biggest tumor diameter to total tumor diameter be a new parameter in the differential diagnosis of agressive and favorable multifocal papillary thyroid microcarcinoma? Oral Oncol. 2017 Feb;65:1-7. doi: 10.1016/j.oraloncology.2016.12.004. Epub 2016 Dec 18. PMID: 28109462.
Thompson AM, Turner RM, Hayen A, et al. A preoperative nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancer. Thyroid. 2014;24(4):675-82. doi:10.1089/thy.2013.0224.
Trésallet C, Seman M, Tissier F, et al. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery. 2014 Nov;156(5):1145-52. doi: 10.1016/j.surg.2014.04.020. Epub 2014 May 27. PMID: 24878452.
Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schüz J, Togawa K, Bray F, Franceschi S, Dal Maso L, Steliarova-Foucher E; IICC-3 contributors. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 2021 Mar;9(3):144-52. doi: 10.1016/S2213-8587(20)30401-0. Epub 2021 Jan 19. PMID: 33482107.
Wan H, Zhang B, Yan D, Xu Z. [Prediction of occult carcinoma in contralateral nodules for unilateral papillary thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Nov;49(11):881-4. Chinese. PMID: 25598363.
Wang F, Yu X, Shen X, et al. The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3241-50. doi: 10.1210/jc.2017-00277. PMID: 28582521; PMCID: PMC5587077.
Wang N, Fang H, Fu C, et al. Associations of adiposity measurements with thyroid nodules in Chinese children living in iodine-sufficient areas: an observational study. BMJ Open. 2017 Oct 30;7(10):e016706. doi: 10.1136/bmjopen-2017-016706. PMID: 29084792; PMCID: PMC5665290.
Wang W, Kong L, Guo H, Chen X. Prevalence and predictor for malignancy of contralateral thyroid nodules in patients with unilateral PTMC: a systematic review and meta-analysis. Endocr Connect. 2021 Jun 21;10(6):656-66. doi: 10.1530/EC-21-0164. PMID: 34010153; PMCID: PMC8240708.
Wang W, Su X, He K, et al. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients. Cancer. 2016 Jan 15;122(2):198-206. doi: 10.1002/cncr.29689. Epub 2015 Oct 27. PMID: 26506214.
Wen X, Jin Q, Cen X, Qiu M, Wu Z. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis. World J Surg Oncol. 2022 Apr 1;20(1):106. doi: 10.1186/s12957-022-02573-7. PMID: 35365171; PMCID: PMC8976349.
Woo J, Kim H, Kwon H. Impact of multifocality on the recurrence of papillary thyroid carcinoma. J Clin Med. 2021 Nov 2;10(21):5144. doi: 10.3390/jcm10215144. PMID: 34768664; PMCID: PMC8584384.
Woo J, Woo J, Kwon H. Optimal surgical extent in patients with unilateral multifocal papillary thyroid carcinoma. Cancers (Basel). 2022 Jan 15;14(2):432. doi: 10.3390/cancers14020432. PMID: 35053595; PMCID: PMC8773701.
Wu Q, Li Y, Wang Y, Hu B. Sonographic features of primary tumor as independent predictive factors for lymph node metastasis in papillary thyroid carcinoma. Clin Transl Oncol. 2015 Oct;17(10):830-4. doi: 10.1007/s12094-015-1313-z. Epub 2015 Jun 4. PMID: 26041723.
Xu J, Ding K, Mu L, et al. Hashimoto’s thyroiditis: a «double-edged sword» in thyroid carcinoma. Front Endocrinol (Lausanne). 2022 Feb 24;13:801925. doi: 10.3389/fendo.2022.801925. PMID: 35282434; PMCID: PMC8907134.
Yamamoto H, Hayashi K, Scherb H. Association between the detection rate of thyroid cancer and the external radiation dose-rate after the nuclear power plant accidents in Fukushima, Japan. Medicine (Baltimore). 2019 Sep;98(37):e17165. doi: 10.1097/MD.0000000000017165. PMID: 31517868; PMCID: PMC6750239.
Yang LM, Li Q, Zhao BW, et al. [Prediction of occult carcinoma in contralateral nodules based on the ultrasonic features of unilateral papillary thyroid carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Apr 7;52(4):259-62. Chinese. doi: 10.3760/cma.j.issn.1673-0860.2017.04.004. PMID: 28441801.
Yeker RM, Shaffer AD, Viswanathan P, et al. Chronic lymphocytic thyroiditis and aggressiveness of pediatric differentiated thyroid cancer. Laryngoscope. 2021 Oct 23:10.1002/lary.29908. doi: 10.1002/lary.29908. Epub ahead of print. PMID: 34687456; PMCID: PMC9033882.
Zablotska LB, Nadyrov EA, Rozhko AV, et al. Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from belarus exposed to radioiodines after the Chernobyl accident. Cancer. 2015 Feb 1;121(3):457-66. doi: 10.1002/cncr.29073. Epub 2014 Oct 28. PMID: 25351557; PMCID: PMC4433039.
Zeng R, Zhao M, Niu H, et al. Relationship between Hashimoto’s thyroiditis and papillary thyroid carcinoma in children and adolescents. Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7778-87. doi: 10.26355/eurrev_201811_16401. PMID: 30536322.
Zhang B, Wu W, Shang X, Huang D, Liu M, Zong L. Incidence and prognosis of thyroid cancer in children: based on the SEER database. Pediatr Surg Int. 2022 Mar;38(3):445-56. doi: 10.1007/s00383-022-05069-3. Epub 2022 Jan 29. PMID: 35091762; PMCID: PMC8831364.
Zhang F, Zheng B, Yu X, Wang X, Wang S, Teng W. Risk factors for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma: a retrospective study and meta-analysis. Front Endocrinol (Lausanne). 2021 Jul 12;12:675643. doi: 10.3389/fendo.2021.675643. PMID: 34322091; PMCID: PMC8310921.
Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ, Zhu QY. Meta-analyses of association between BRAF(V600E) mutation and clinicopathological features of papillary thyroid carcinoma. Cell Physiol Biochem. 2016;38(2):763-76. doi: 10.1159/000443032. Epub 2016 Feb 15. PMID: 26871894.
Zhang T, He L, Wang Z, et al. The differences between multifocal and unifocal papillary thyroid carcinoma in unilateral lobe: a meta-analysis. Front Oncol. 2021 Sep 16;11:657237. doi: 10.3389/fonc.2021.657237. PMID: 34604025; PMCID: PMC8483575.
Zhao Q, Ming J, Liu C, et al. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann Surg Oncol. 2013 Mar;20(3):746-52. doi: 10.1245/s10434-012-2654-2. Epub 2012 Sep 13. PMID: 22972508.
Zhao S, Jia X, Fan X, et al. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study. Medicine (Baltimore). 2019 Dec;98(50):e18213. doi: 10.1097/MD.0000000000018213. PMID: 31852078; PMCID: PMC6922396.
Zhou B, Wei L, Qin J. Does multifocal papillary thyroid microcarcinoma with a total tumor diameter > 1 cm indicate poor biological behavior? The evidence is insufficient. Endocr Pract. 2021 Feb;27(2):131-6. doi: 10.4158/EP-2020-0460. Epub 2020 Dec 8. PMID: 33547013.
Zhou Y, Sun Z, Zhou Y, et al. Thyroid antibody status exerts insignificant effect on lymph node metastasis of thyroid cancer. Transl Cancer Res. 2020 Oct;9(10):6423-30. doi: 10.21037/tcr-20-1941. PMID: 35117250; PMCID: PMC8799275.
Zhu J, Zheng J, Li L, et al. Application of machine learning algorithms to predict central lymph node metastasis in T1-T2, non-invasive, and clinically node negative papillary thyroid carcinoma. Front Med (Lausanne). 2021 Mar 9;8:635771. doi: 10.3389/fmed.2021.635771. PMID: 33768105; PMCID: PMC7986413.
##submission.downloads##
Опубліковано
Номер
Розділ
Ліцензія
Авторське право (c) 2022 Автори
Ця робота ліцензується відповідно до Creative Commons Attribution-NoDerivatives 4.0 International License.
